SUPPORT LINE

0300 111 1234

Tolvaptan Study - Implications for ADPKD Patients

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Listen to Dr Donal O'Donoghue, the former National Clinical Director of Kidney Care in England, discuss the Tolvaptan trial and its implications for ADPKD patients. (20 minute video skype chat.)

Click the link here. You may have to register but the process is quick and you should get immediate access.

Print Email

Latest Tweets

RT @actiononsalt: Food Industry must accept they have a role to play in helping their consumers eat less salt and fat and take responsibili…

PKD Charity UK PKD Charity UK

RT @actiononsalt: Food Industry must accept they have a role to play in helping their consumers eat less salt and fat and take responsibili…

by PKD Charity UK

PKD Charity is a Member of

  • Fundraising Regulator Website
  • Visit PKD International website
  • Visit Ciliopathy Alliance website
  • Visit the Genetic Alliance UK website
  • Rare Disease UK Website
  • Specialised Healthcare Alliance Website
  • FEDERG Website
  • Visit EURORDIS website